Noticias y Actividades de Clearside Biomedical
Presencia
Sede: Estados Unidos
Clearside Biomedical es una empresa que cotiza bajo el símbolo de cotización CLSD (US).
Fusión, adquisición y financiación con participación de Clearside Biomedical.
- Clearside Biomedical has gone out of its bankruptcy protection (publicado el 15 de julio de 2026).
Ejecutivos
Ver el organigrama con sus 17 ejecutivos principales
Biografías más buscadas en Clearside Biomedical
- George Lasezkay, Chief Executive Officer and Director
- Christy Shaffer, Director
- Clay Thorp, Chairman of the Board
Crear su alerta
para seguir los movimientos de los ejecutivos en Clearside Biomedical.
Biotecnología
Clearside Biomedical tiene 2.428 competidores entre los que se incluyen Lonza (Suiza), Vertex Pharmaceuticals (Estados Unidos) y Eurofins (Luxemburgo).
Popular M&A news in Biotecnología
- Eli Lilly has announced the acquisition of AtaiBeckley (publicado el 17 de julio de 2026).
- GSK ha Nuvalent adquirido (publicado el 17 de julio de 2026).
- Clearside Biomedical has gone out of its bankruptcy protection (publicado el 15 de julio de 2026).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de Clearside Biomedical
- Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process | Clearside Biomedical, Inc.- IR Site
- News | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting | Clearside Biomedical, Inc.- IR Site
- News | Clearside Biomedical, Inc.- IR Site
- View more press releases Close
Redes sociales sobre Clearside Biomedical
- Clearside Biomedical en Wikipedia, Google News y Yahoo Finance
- Clearside Biomedical en LinkedIn, Twitter y YouTube
